兴奋性谵妄:一项系统评价
该系统评价检索MEDLINE、Ovid、Web of Knowledge和Cochrane Library截至2017年3月18日的文献,并检索灰色文献及官方警察或医学专家报告,由两名研究者独立评估,最终纳入66篇文献。ExDS发生率随医学或法医学背景差异很大,死亡率估计最高达8.3%–16.5%,患者以男性为主,男性、年轻、非裔美国人种族和超重为独立危险因素。病理生理假说多涉及多巴胺能通路,多数病例与精神兴奋剂使用或精神科患者相关或两者兼有。推荐的治疗为对症治疗,常用苯二氮䓬类或抗精神病药物快速镇静,氯胺酮被建议作为替代。作者结论认为研究总体质量差,缺乏普遍认可的定义,尚无比较研究能判定某种治疗是否优于另一种。
要点
- ExDS死亡率估计最高达8.3%–16.5%,作者认为高死亡率可能源于定义不一致和报告偏倚。
- 多数病例与精神兴奋剂使用或精神科患者相关或两者兼有,男性、年轻、非裔美国人种族和超重为独立危险因素。
- 推荐的治疗为对症治疗,常用苯二氮䓬类或抗精神病药物快速镇静,氯胺酮被建议作为替代。
- 尚无比较研究能判定ExDS中某种治疗方式是否优于另一种。
- 缺乏普遍认可的定义,ExDS诊断仍主要基于临床主观标准的综合征。
适用人群与场景
- 多数ExDS病例发生在使用精神兴奋剂者、精神科患者或两者兼有的人群中。
- 患者以男性为主;男性、年轻、非裔美国人种族和超重为独立危险因素。
处置流程与药物剂量
- 推荐的治疗为对症治疗,常采用苯二氮䓬类或抗精神病药物快速镇静。
- 氯胺酮被建议作为替代方案。
研究设计与关键结果
- 系统评价检索MEDLINE、Ovid、Web of Knowledge和Cochrane Library截至2017年3月18日的文献,并检索灰色文献(Google Scholar)及官方警察或医学专家报告。
- 共审查3604篇文献的标题和摘要,全文审阅284篇可能相关的文献,最终纳入66篇进行最终评价。
- 66篇中6篇涉及ExDS定义,24篇涉及流行病学,38篇涉及病理生理,27篇涉及管理。
- ExDS发生率随医学或法医学背景差异很大。
- 死亡率估计最高达8.3%–16.5%。
- 病理生理假说多涉及多巴胺能通路。
- 尚无比较研究能判定ExDS中某种治疗方式是否优于另一种。
证据类型、等级与局限
- 证据类型:系统评价。
- 研究总体质量差。
- 缺乏普遍认可的定义,ExDS诊断仍主要基于临床主观标准的综合征。
- 高死亡率可能源于定义不一致和报告偏倚。
- 尚无比较研究能判定ExDS中某种治疗方式是否优于另一种。
对床旁实践的改变
- 作者认为ExDS是真实存在的临床实体,仍可致命,且可能具有特定的机制和危险因素。
- 作者指出尚无比较研究能判定ExDS中某种治疗方式是否优于另一种,现有推荐为对症治疗,常采用苯二氮䓬类或抗精神病药物快速镇静,氯胺酮被建议作为替代。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to clarify the definition, epidemiology, and pathophysiology of excited delirium syndrome (ExDS) and to summarize evidence-based treatment recommendations.
METHODS: We conducted a systematic literature search of MEDLINE, Ovid, Web of Knowledge, and Cochrane Library for articles published to March 18, 2017. We also searched the gray literature (Google Scholar) and official police or medical expert reports to complete specific epidemiologic data. Search results and full-text articles were independently assessed by two investigators and agreements between reviewers assessed with K statistics. We classified articles by study type, setting, and evidence level.
RESULTS: After reviewing the title and abstract of 3,604 references, we fully reviewed 284 potentially relevant references, from which 66 were selected for final review. Six contributed to the definition of ExDS, 24 to its epidemiology, 38 to its pathophysiology, and 27 to its management. The incidence of ExDS varies widely with medical or medicolegal context. Mortality is estimated to be as much as 8.3% to 16.5%. Patients are predominantly male. Male sex, young age, African-American race, and being overweight are independent risk factors. Pathophysiology hypotheses mostly implicate dopaminergic pathways. Most cases occur with psychostimulant use or among psychiatric patients or both. Proposed treatments are symptomatic, often with rapid sedation with benzodiazepines or antipsychotic agents. Ketamine is suggested as an alternative.
CONCLUSION: The overall quality of studies was poor. A universally recognized definition is lacking, remaining mostly syndromic and based on clinical subjective criteria. High mortality rate may be due to definition inconsistency and reporting bias. Our results suggest that ExDS is a real clinical entity that still kills people and that has probably specific mechanisms and risk factors. No comparative study has been performed to conclude whether one treatment approach is preferable to another in the case of ExDS.
参考来源
- Gonin P, Beysard N, Yersin B, et al. Excited Delirium: A Systematic Review. Acad Emerg Med. 2017. PMID: 28990246. doi:10.1111/acem.13330
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。